The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Refining the use of adjuvant oxaliplatin in clinical stage II or III rectal adenocarcinoma.
 
Ofer Margalit
Travel, Accommodations, Expenses - Medison
 
Ronac Mamtani
Consulting or Advisory Role - Genentech/Roche; Takeda
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; EMD Serono; Genentech; Guardant Health (Inst); Karyopharm Therapeutics; Merck; Roche; Symphony Evolution
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Yu-Xiao Yang
No Relationships to Disclose
 
Yaacov Richard Lawrence
Consulting or Advisory Role - Clinigen Group
Research Funding - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Pfizer
 
Samir Abu-Gazala
No Relationships to Disclose
 
Kim Anna Reiss
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology; Lilly (Inst); Tesaro (Inst)
 
Talia Golan
Honoraria - Bristol-Myers Squibb; MSD; Rafael Pharmaceuticals
Consulting or Advisory Role - Abbvie; AstraZeneca
 
Naama Halpern
No Relationships to Disclose
 
Dan Aderka
Consulting or Advisory Role - Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Bruce J. Giantonio
No Relationships to Disclose
 
Einat Shacham-Shmueli
No Relationships to Disclose
 
Ben Boursi
No Relationships to Disclose